SCH00013, a novel Ca2+ sensitizer with positive inotropic and no chronotropic action in heart failure

Naoto Tadano, Sachio Morimoto, Akira Yoshimura, Makoto Miura, Kimitomo Yoshioka, Mitsuo Sakato, Iwao Ohtsuki, Yoshikazu Miwa, Fumi Takahashi-Yanaga, Toshiyuki Sasaguri

Research output: Contribution to journalArticlepeer-review

8 Citations (Scopus)

Abstract

We investigated the effects of the agent SCH00013 on Ca2+- induced force generation in rabbit skinned cardiac muscle fibers and in vivo cardiac function in high-pacing-induced heart failure dogs. The Ca 2+-induced force generation in skinned cardiac muscle fibers was determined at pH 6.2-7.4, and SCH00013 was found to have a significant Ca 2+ sensitizing effect at pH 7.2 to 7.4. There was no significant difference in the Ca2+ sensitizing action between the enantiomers of SCH00013. The Ca2+ sensitizing effect of SCH00013 was dependent on the sarcomere length, being significant only at a long sarcomere length. SCH00013 elicited a positive inotropic effect at more than 0.3 and 1 mg/kg, i.v. in normal and heart failure dogs, respectively, with no chronotropic action. These results strongly suggested that SCH00013 is a novel Ca2+ sensitizer that elicits a positive inotropic and no chronotropic effect in heart failure, probably through enhancing the Frank-Starling mechanism.

Original languageEnglish
Pages (from-to)53-60
Number of pages8
JournalJournal of Pharmacological Sciences
Volume97
Issue number1
DOIs
Publication statusPublished - Jan 2005

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Pharmacology

Fingerprint Dive into the research topics of 'SCH00013, a novel Ca<sup>2+</sup> sensitizer with positive inotropic and no chronotropic action in heart failure'. Together they form a unique fingerprint.

Cite this